Publications

Publications pour l'équipe Oncostat

Titre Publication Type Publication year Auteur
Clinical outcomes after intensity-modulated proton therapy with concurrent chemotherapy for inoperable non-small cell lung cancer journalArticle 2019 Elhammali, A.; Blanchard, P.; Yoder, A.; Liao, Z.; Zhang, X.; Ronald Zhu, X.; Allen, P. K.; Jeter, M.; Welsh, J.; Nguyen, Q. N.
Prospective in silico study of the feasibility and dosimetric advantages of MRI-guided dose adaptation for human papillomavirus positive oropharyngeal cancer patients compared with standard IMRT journalArticle 2018 Mohamed, A. S. R.; Bahig, H.; Aristophanous, M.; Blanchard, P.; Kamal, M.; Ding, Y.; Cardenas, C. E.; Brock, K. K.; Lai, S. Y.; Hutcheson, K. A.; Phan, J.; Wang, J.; Ibbott, G.; Gabr, R. E.; Narayana, P. A.; Garden, A. S.; Rosenthal, D. I.; Gunn, G. B.; Fuller, C. D.; Group, M. D. Anderson MRLinac Development Working
Statistical controversies in clinical research: prognostic gene signatures are not (yet) useful in clinical practice journalArticle 2016 Michiels, S.; Ternes, N.; Rotolo, F.
Percutaneous bone biopsies: comparison between flat-panel cone-beam CT and CT-scan guidance journalArticle 2015 Tselikas, L.; Joskin, J.; Roquet, F.; Farouil, G.; Dreuil, S.; Hakime, A.; Teriitehau, C.; Auperin, A.; de Baere, T.; Deschamps, F.
Is primary tumour resection associated with survival improvement in patients with colorectal cancer and unresectable synchronous metastases? A pooled analysis of individual data from four randomised trials journalArticle 2015 Faron, M.; Pignon, J. P.; Malka, D.; Bourredjem, A.; Douillard, J. Y.; Adenis, A.; Elias, D.; Bouché, O.; Ducreux, M.
Post-first-line FOLFOX chemotherapy for grade 3 neuroendocrine carcinoma journalArticle 2015 Hadoux, J.; Malka, D.; Planchard, D.; Scoazec, J. Y.; Caramella, C.; Guigay, J.; Boige, V.; Leboulleux, S.; Burtin, P.; Berdelou, A.; Loriot, Y.; Duvillard, P.; Chougnet, C. N.; Déandréis, D.; Schlumberger, M.; Borget, I.; Ducreux, M.; Baudin, E.
Impact of Skin Toxicities Associated with Targeted Cancer Therapies on Body Image: A Prospective Study journalArticle 2016 Charles, C.; Razavi, D.; Bungener, C.; Mateus, C.; Lanoy, E.; Verschoore, M.; Dauchy, S.; Robert, C.
Unilateral or bilateral irradiation in cervical lymph node metastases of unknown primary? A retrospective cohort study journalArticle 2019 Pflumio, C.; Troussier, I.; Sun, X. S.; Salleron, J.; Petit, C.; Caubet, M.; Beddok, A.; Calugaru, V.; Servagi-Vernat, S.; Castelli, J.; Miroir, J.; Krengli, M.; Giraud, P.; Romano, E.; Khalifa, J.; Dore, M.; Blanchard, N.; Coutte, A.; Dupin, C.; Sumodhee, S.; Pointreau, Y.; Patel, S.; Rehailia-Blanchard, A.; Catteau, L.; Bensadoun, R. J.; Tao, Y.; Roth, V.; Geoffrois, L.; Faivre, J. C.; Thariat, J.
Empirical extensions of the lasso penalty to reduce the false discovery rate in high-dimensional Cox regression models journalArticle 2016 Ternes, N.; Rotolo, F.; Michiels, S.
Impact of Skin Toxicities Associated with Targeted Cancer Therapies on Body Image: A Prospective Study journalArticle 2016 Charles, C.; Razavi, D.; Bungener, C.; Mateus, C.; Lanoy, E.; Verschoore, M.; Dauchy, S.; Robert, C.
Screening in asymptomatic SDHx mutation carriers: added value of ¹⁸F-FDG PET/CT at initial diagnosis and 1-year follow-up journalArticle 2015 Lepoutre-Lussey, C.; Caramella, C.; Bidault, F.; Déandreis, D.; Berdelou, A.; Al Ghuzlan, A.; Hartl, D.; Borget, I.; Gimenez-Roqueplo, A. P.; Dumont, F.; Deschamps, F.; Nascimento, C.; Lumbroso, J.; Guillaud Bataille, M.; Schlumberger, M.; Baudin, E.; Leboulleux, S.
Burnout among young European oncologists: a call for action journalArticle 2017 Blanchard, P.
A Systematic Review of the Level of Evidence in Economic Evaluations of Medical Devices: The Example of Vertebroplasty and Kyphoplasty journalArticle 2015 Martelli, N.; Devaux, C.; van den Brink, H.; Pineau, J.; Prognon, P.; Borget, I.
Results of a multicenter phase I dose-finding trial of hyperthermic intraperitoneal cisplatin after neoadjuvant chemotherapy and complete cytoreductive surgery and followed by maintenance bevacizumab in initially unresectable ovarian cancer journalArticle 2016 Gouy, S.; Ferron, G.; Glehen, O.; Bayar, A.; Marchal, F.; Pomel, C.; Quenet, F.; Bereder, J. M.; Le Deley, M. C.; Morice, P.
Health state utility and quality of life measures in patients with chronic myeloid leukemia in France journalArticle 2021 Foulon S, Cony-Makhoul P, Guerci-Bresler A, Daban M, Kapso R, Tubert-Bitter P, Bonastre J
Sentinel node biopsy in early oral squamous cell carcinomas: Long-term follow-up and nodal failure analysis journalArticle 2018 Moya-Plana, A.; Aupérin, A.; Guerlain, J.; Gorphe, P.; Casiraghi, O.; Mamelle, G.; Melkane, A.; Lumbroso, J.; Janot, F.; Temam, S.
Quality of life after brachytherapy or bilateral nerve-sparing robot-assisted radical prostatectomy for prostate cancer: a prospective cohort journalArticle 2017 Blanchard, P.; Davis, J. W.; Frank, S. J.; Kim, J.; Pettaway, C. A.; Pugh, T. J.; Pisters, L. L.; Ward, J. F.; Choi, S.; Chapin, B. F.; Hoffman, K.; Navai, N.; Achim, M.; McGuire, S. E.; Matin, S. F.; Nguyen, Q.; Mahmood, U.; Graber, W. J.; Chen, H. C.; Wang, X.; Kuban, D. A.
The Genomic Grade Assay Compared With Ki67 to Determine Risk of Distant Breast Cancer Recurrence journalArticle 2016 Ignatiadis, M.; Azim, H. A.; Desmedt, C.; Veys, I.; Larsimont, D.; Salgado, R.; Lyng, M. B.; Viale, G.; Leyland-Jones, B.; Giobbie-Hurder, A.; Kammler, R.; Dell'Orto, P.; Rothe, F.; Laios, I.; Ditzel, H. J.; Regan, M. M.; Piccart, M.; Michiels, S.; Sotiriou, C.
Adjuvant chemotherapy for resected early-stage non-small cell lung cancer journalArticle 2015 Burdett, S.; Pignon, J. P.; Tierney, J.; Tribodet, H.; Stewart, L.; Le Pechoux, C.; Aupérin, A.; Le Chevalier, T.; Stephens, R. J.; Arriagada, R.; Higgins, J. P.; Johnson, D. H.; Van Meerbeeck, J.; Parmar, M. K.; Souhami, R. L.; Bergman, B.; Douillard, J. Y.; Dunant, A.; Endo, C.; Girling, D.; Kato, H.; Keller, S. M.; Kimura, H.; Knuuttila, A.; Kodama, K.; Komaki, R.; Kris, M. G.; Lad, T.; Mineo, T.; Piantadosi, S.; Rosell, R.; Scagliotti, G.; Seymour, L. K.; Shepherd, F. A.; Sylvester, R.; Tada, H.; Tanaka, F.; Torri, V.; Waller, D.; Liang, Y.
New French Coverage with Evidence Development for Innovative Medical Devices: Improvements and Unresolved Issues journalArticle 2016 Martelli, N.; van den Brink, H.; Borget, I.
Robotic Prophylactic Nipple-Sparing Mastectomy with Immediate Prosthetic Breast Reconstruction: A Prospective Study journalArticle 2018 Sarfati, B.; Struk, S.; Leymarie, N.; Honart, J. F.; Alkhashnam, H.; Tran de Fremicourt, K.; Conversano, A.; Rimareix, F.; Simon, M.; Michiels, S.; Kolb, F.
Impact of gender on efficacy and acute toxicity of alkylating agent -based chemotherapy in Ewing sarcoma: secondary analysis of the Euro-Ewing99-R1 trial journalArticle 2015 van den Berg, H.; Paulussen, M.; Le Teuff, G.; Judson, I.; Gelderblom, H.; Dirksen, U.; Brennan, B.; Whelan, J.; Ladenstein, R. L.; Marec-Berard, P.; Kruseova, J.; Hjorth, L.; Kuhne, T.; Brichard, B.; Wheatley, K.; Craft, A.; Juergens, H.; Gaspar, N.; Le Deley, M. C.; Euro, Ewing Group
How to Reliably Assess Nodal Status in Distal Pancreatectomy for Adenocarcinoma journalArticle 2018 Faron, M.; Vuarnesson, H.; Boher, J. M.; Bachellier, P.; Sauvanet, A.; Sa Cunha, A.; Le Treut, Y. P.; Mabrut, J. Y.; Delpero, J. R.; Paye, F.
Progression-free survival as surrogate end point for overall survival in clinical trials of HER2-targeted agents in HER2-positive metastatic breast cancer journalArticle 2016 Michiels, S.; Pugliano, L.; Marguet, S.; Grun, D.; Barinoff, J.; Cameron, D.; Cobleigh, M.; Di Leo, A.; Johnston, S.; Gasparini, G.; Kaufman, B.; Marty, M.; Nekljudova, V.; Paluch-Shimon, S.; Penault-Llorca, F.; Slamon, D.; Vogel, C.; von Minckwitz, G.; Buyse, M.; Piccart, M.
Low response rate after cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: long-term results of the UNICANCER ACCORD 16 phase II trial journalArticle 2015 Levy, A.; Azria, D.; Pignon, J. P.; Delarochefordiere, A.; Martel-Lafay, I.; Rio, E.; Malka, D.; Conroy, T.; Miglianico, L.; Becouarn, Y.; Malekzadeh, K.; Leclercq, J.; Juzyna, B.; Ezra, P.; Lemanski, C.; Deutsch, E.
Mortality from Circulatory System Diseases among French Uranium Miners: A Nested Case-Control Study journalArticle 2015 Drubay, D.; Caer-Lorho, S.; Laroche, P.; Laurier, D.; Rage, E.
The Use of Indirect Comparisons in Medicines Evaluation for their Access To Reimbursement by the Has journalArticle 2015 Guichard, M.; D'Andon, A.; Rumeau Pichon, C.; Borget, I.
Impact of dermatologic adverse events induced by targeted therapies on quality of life journalArticle 2016 Charles, C.; Bungener, C.; Razavi, D.; Mateus, C.; Routier, E.; Lanoy, E.; Verschoore, M.; Robert, C.; Dauchy, S.
Individual patient data network meta-analysis using either restricted mean survival time difference or hazard ratios: is there a difference? A case study on locoregionally advanced nasopharyngeal carcinomas journalArticle 2019 Petit, C.; Blanchard, P.; Pignon, J. P.; Lueza, B.
surrosurv: An R package for the evaluation of failure time surrogate endpoints in individual patient data meta-analyses of randomized clinical trials journalArticle 2018 Rotolo, F.; Paoletti, X.; Michiels, S.
Factors associated with success of image-guided tumour biopsies: Results from a prospective molecular triage study (MOSCATO-01) journalArticle 2016 Tacher, V.; Le Deley, M. C.; Hollebecque, A.; Deschamps, F.; Vielh, P.; Hakime, A.; Ileana, E.; Abedi-Ardekani, B.; Charpy, C.; Massard, C.; Rosellini, S.; Gajda, D.; Celebic, A.; Ferte, C.; Ngo-Camus, M.; Gouissem, S.; Koubi-Pick, V.; Andre, F.; Vassal, G.; Deandreis, D.; Lacroix, L.; Soria, J. C.; De Baere, T.
Impact of dermatologic adverse events induced by targeted therapies on quality of life journalArticle 2016 Charles, C.; Bungener, C.; Razavi, D.; Mateus, C.; Routier, E.; Lanoy, E.; Verschoore, M.; Robert, C.; Dauchy, S.
Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial journalArticle 2015 Le Tourneau, C.; Delord, J. P.; Goncalves, A.; Gavoille, C.; Dubot, C.; Isambert, N.; Campone, M.; Tredan, O.; Massiani, M. A.; Mauborgne, C.; Armanet, S.; Servant, N.; Bieche, I.; Bernard, V.; Gentien, D.; Jezequel, P.; Attignon, V.; Boyault, S.; Vincent-Salomon, A.; Servois, V.; Sablin, M. P.; Kamal, M.; Paoletti, X.; investigators, Shiva
INTRODUCTION OF INNOVATIVE MEDICAL DEVICES AT FRENCH UNIVERSITY HOSPITALS: AN OVERVIEW OF HOSPITAL-BASED HEALTH TECHNOLOGY ASSESSMENT INITIATIVES journalArticle 2015 Martelli, N.; Billaux, M.; Borget, I.; Pineau, J.; Prognon, P.; van den Brink, H.
Results and Survival of Locally Advanced AJCC 7th Edition T4a Laryngeal Squamous Cell Carcinoma Treated with Primary Total Laryngectomy and Postoperative Radiotherapy journalArticle 2016 Gorphe, P.; Matias, M.; Moya-Plana, A.; Tabarino, F.; Blanchard, P.; Tao, Y.; Janot, F.; Temam, S.
Radiation therapy to the primary in metastatic prostate cancer: palliation only or altering tumor biology? journalArticle 2017 Blanchard, P.; Bossi, A.; Fizazi, K.
Dosimetric advantages of intensity-modulated proton therapy for oropharyngeal cancer compared with intensity-modulated radiation: A case-matched control analysis journalArticle 2016 Holliday, E. B.; Kocak-Uzel, E.; Feng, L.; Thaker, N. G.; Blanchard, P.; Rosenthal, D. I.; Gunn, G. B.; Garden, A. S.; Frank, S. J.
Percutaneous lung thermal ablation of non-surgical clinical N0 non-small cell lung cancer: results of eight years' experience in 87 patients from two centers journalArticle 2015 Palussiere, J.; Lagarde, P.; Auperin, A.; Deschamps, F.; Chomy, F.; de Baere, T.
Quality of Life and Cost-Effectiveness Assessment of Radioiodine Ablation Strategies in Patients With Thyroid Cancer: Results From the Randomized Phase III ESTIMABL Trial journalArticle 2015 Borget, I.; Bonastre, J.; Catargi, B.; Déandréis, D.; Zerdoud, S.; Rusu, D.; Bardet, S.; Leenhardt, L.; Bastie, D.; Schvartz, C.; Vera, P.; Morel, O.; Benisvy, D.; Bournaud, C.; Bonichon, F.; Kelly, A.; Toubert, M. E.; Leboulleux, S.; Journeau, F.; Benhamou, E.; Schlumberger, M.
Advantages and disadvantages of 3-dimensional printing in surgery: A systematic review journalArticle 2016 Martelli, N.; Serrano, C.; van den Brink, H.; Pineau, J.; Prognon, P.; Borget, I.; El Batti, S.